Trial Profile
Phase I trial of insulin-coated gold nanoparticles administered in a transbuccal film to healthy volunteers.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 12 Jun 2023
Price :
$35
*
At a glance
- Drugs Insulin (Primary)
- Indications Diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- 16 May 2023 According to Biodexa Pharmaceuticals, 20-F filing, Midatech has changed its name to Biodexa Pharmaceuticals
- 30 Nov 2017 According to a Aquestive Therapeutics media release, MonoSol Rx changed its name to Aquestive Therapeutics
- 03 May 2012 Top-line results will be presented at the European Summit for Clinical Nanomedicine (CLINAM) in 2012 as reported by Midatech and Monosol Rx.